Gyre Therapeutics, Inc.
GYRE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $117M | $106M | +10.2% |
| Operating income | $11.5M | $16.2M | −28.9% |
| Net income | $5.03M | $12.1M | −58.4% |
Questions
- What was Gyre Therapeutics's revenue in FY2025?
- $117M in FY2025 (Fiscal year ended Dec 31, 2025), +10.2% vs $106M a year earlier, per its 10-K filed Mar 2026.
- Was Gyre Therapeutics profitable in FY2025?
- Yes: net income was $5.03M and operating income $11.5M in FY2025.